[EN] ANTAGONISTS OF THE TOLL-LIKE RECEPTOR 1/2 COMPLEX<br/>[FR] ANTAGONISTES DU COMPLEXE DE RÉCEPTEUR 1/2 DE TYPE TOLL
申请人:UNIV COLORADO REGENTS
公开号:WO2014022287A1
公开(公告)日:2014-02-06
Provided are compounds, compositions and methods for treating Toll-like receptor 1/2 complex (TLRI/2) related inflammatory disorders. Small molecules, based on the benzotropolone scaffold, capable of influencing downstream signaling are dislcosed as well as methods of making and modifying these molecules. Also provided are methods for treating a subject for a clinical condition associated with Toll¬ like receptor complex 1/2 activation, comprising administering to the subject an effective amount of a benzotropolone compound.
提供了用于治疗Toll样受体1/2复合物(TLR1/2)相关炎症性疾病的化合物、组合物和方法。基于苯并三酮骨架的小分子,能够影响下游信号传导,以及制备和修改这些分子的方法也已披露。还提供了用于治疗与Toll样受体复合物1/2激活相关的临床状况的方法,包括向受试者施用有效量的苯并三酮化合物。